Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells

Most breast cancer patients treated with anti-oestrogens will eventually develop resistance towards treatment. Therefore it is important to find new therapeutic agents effective for treatment of patients relapsing on anti-oestrogen. The vitamin D analogue EB1089 (Seocalcitol(TM)) is a promising new...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, S S, Heiberg, I, Lykkesfeldt, A E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363804/
https://www.ncbi.nlm.nih.gov/pubmed/11237391
http://dx.doi.org/10.1054/bjoc.2000.1646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363804/
https://www.ncbi.nlm.nih.gov/pubmed/11237391
http://dx.doi.org/10.1054/bjoc.2000.1646

Ejemplares similares